Michel Kalamarides

Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: an international consensus recommendation

Eric Legius, Ludwine Messiaen, P. Wolkenstein et al. · Genetics in Medicine · 2021 · 771 citations · Full text

Medicine, Dermatology, Ophthalmology +14

WHO grade II and III meningiomas: a study of prognostic factors

Anne Durand, François Labrousse, A. Jouvet et al. · Journal of Neuro-Oncology · 2009 · 339 citations

Medicine, Neurosurgery, Oncology +14

Updated diagnostic criteria and nomenclature for neurofibromatosis type 2 and schwannomatosis: An international consensus recommendation

Scott R. Plotkin, Ludwine Messiaen, Eric Legius et al. · Genetics in Medicine · 2022 · 276 citations · Full text

Medicine, Genetics, Neurology +16

High Incidence of Activating<scp><i>TERT</i></scp>Promoter Mutations in Meningiomas Undergoing Malignant Progression

Stéphane Goutagny, Jean‐Charles Nault, Maxime Mallet et al. · Brain Pathology · 2013 · 248 citations · Full text

Medicine, Genetics, Oncology +15

<i>Nf2</i> gene inactivation in arachnoidal cells is rate-limiting for meningioma development in the mouse

Michel Kalamarides, Michiko Niwa‐Kawakita, H. Leblois et al. · Genes & Development · 2002 · 226 citations · Full text

Medicine, Genetics, Oncology +13